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We investigated opioid peptide actions on somatic calcium-dependent action potentials of 
dorsal root ganglion (DRG) neurons grown in primary dissociated cell culture. We report that 
leucine-enkephalin decreased the duration and amplitude of DRG somatic calcium-dependent action 
potentials. The opioid peptide action was dose-dependent over 20 nM to 5 #M and was antagonized 
by naloxone, consistent with mediation by opiate receptors. Thus, DRG neuron membranes have 
opiate receptors which act to decrease calcium influx. It is likely, therefore, that opiate receptors on 
the somata of DRG neurons in culture are functionally similar to opiate receptors on primary afferent 
terminals. 
Opiates can act directly at the level o f  the spinal cord to produce analgesia 37. The 
mechanism of  opiate mediated analgesia at spinal levels is thought  to involve depres- 
sion o f  neurotransmit ter  release f rom primary afferents conveying nociceptive infor- 
mat ion 4, 7,s, 11,12,19,23,26,29,32. Release of  neurotransmit ter  is associated with activation 
o f  voltage-dependent calcium conductance in synaptic terminal membranes21,24, 25. It 
has been suggested that  opiates depress neurotransmit ter  release by reducing pre- 
synaptic calcium entryS,13-15, ~9. However,  presynaptic opiate actions to decrease 
calcium influxS, la-15 cannot  be investigated directly since intracellular recording tech- 
niques cannot  be applied to pr imary afferent synaptic terminals. The somatic 
membrane  o f  dorsal roo t  ganglion ( D R G )  neurons has a voltage-dependent calcium 
conductance 6,1°,18,27,2s,3° which is sensitive to a variety o f  neurotransmittersg,10, 29. 
Thus, the D R G  neuron soma membrane,  with the advantage o f  permitting study by 
intracellular recording, has been proposed as a model for synaptic terminal membrane  
(refs. 9, 10, 29). I f  the model is valid, transmitter effects on D R G  neuron somatic cal- 
c ium-dependent  action potentials reflect effects on calcium entry at synaptic terminals 
and, hence, on transmitter release. The use o f  somatic membrane  as a model for 
terminal membrane  has been supported by several studiesg,10,17,22, 29. 
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Mudge et al. 29 recently demonstrated that the opioid peptide, D-Ala2-Met-enke - 
phalinamide decreased the duration and amplitude of  somatic calcium-dependent 
action potentials in chick D R G  neurons grown in pr imary dissociated cell culture, an 
action correlated with a reduction o f  substance P release. This finding has not been 
confirmed since the calcium component  o f  action potentials was unaltered by 
enkephalins in other studies 16,33,36. In this study, we used intracellular recording 
techniques to investigate the actions of  leucine-enkephalin (L-ENK)  on somatic action 
potential o f  murine D R G  neurons grown in pr imary dissociated cell culture. We 
report  that L -ENK at 20 nM to 5 ffM decreased the durat ion and amplitude of  the 
calcium component  o f  D R G  action potentials. The opioid peptide effect was dose- 
dependent and antagonized by naloxone, consistent with mediation by opiate recep- 
tors. 
Cell cultures used in these experiments were prepared from spinal cords with 
attached dorsal root  ganglia dissected from 13-14-day-old fetal mice as previously 
described 31. Experimental medium was a balanced salt solution containing (in mM):  
NaCI, 137; KC1, 5.3; MgCI2, 0.8; CaCIe, 5.0; Tris-hydrochloride, 15; glucose, 5.6: 
te t raethylammonium-chloride (TEA), 5.0. TEA, which decreases voltage-dependent 
potassium conductance 1, was used to enhance the calcium component  o f  D R G  neuron 
action potentials TM. In TEA-free medium D R G  neuron somatic action potential 
duration was about  2.0 ms with the initial 0.6 ms dependent upon sodium and the 
remainder upon calcium is. Medium containing 5 mM TEA increased the duration o f  
the calcium component  to 3-25 ms. Thus, in TEA-containing medium, the sodium 
componen t  o f  action potentials is brief in comparison to the calcium component .  
Aliquots o f  L - E N K  (Calbiochem-Behring Corporat ion or Sigma Chemical 
Company) ,  dissolved in distilled water at 1 mM and frozen in plastic tubes, were 
thawed and serially diluted in experimental medium to appropriate concentrations. 
D R G  neurons were impaled with high resistance (20-40 M ~ )  glass micropipettes filled 
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Fig. 1. L-ENK decreases the duration and amplitude of the calcium component of DRG neuron 
somatic action potentials. Depolarizing current pulses (applied at arrow) evoked action potentials 
from resting membrane potential at 15 s intervals. Action potentials evoked in medium containing 5 
mM TEA had durations of 5-20 ms and were dependent upon both sodium and calcium. 
Approximately the first millisecond is dependent upon sodium with the remaining broad plateau 
dependent upon calcium. A: data in this and following figures are superimposed action potentials 
evoked prior to (1) and subsequent to (2) L-ENK application. Control action potential duration was 
I I ms (1), measured from onset of the depolarizing stimulus to the point where potential during 
repolarization intersected with resting membrane potential. Pressure ejection of 500 nM L-ENK for 1 
s and delivered 4 s prior to evoking an action potential decreased the duration and amplitude of the 
calcium-dependent action potential to 6 ms (2). B : action potential duration returned to baseline over 
the next 1.5 rain (7). Resting membrane potential was --61 inV. 
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with 4 M potassium acetate and somatic calcium-dependent action potentials were 
evoked from resting membrane potential with 100 #s depolarizing current pulses at a 
frequency of 4/min. L-ENK was applied by pressure ejection (0.5-2.0 psi) from micro- 
pipettes with tip diameters of 2-5/~m. Naloxone (Endo Laboratories) was applied by 
diffusion from 15-25/~m diameter micropipettes positioned approximately 10-15 pm 
from the DRG. Three micropipettes were routinely used during experiments which 
allowed dose-dependent peptide and naloxone actions to be assessed on single 
neurons. 
A 1 s application of L-ENK at 1 #M delivered 3-4 s prior to evoking an action 
potential, did not affect action potential duration or configuration in 26 ~ (n ---- 115) of 
DRG neurons. In the remaining cells, the calcium component of action potentials was 
decreased in amplitude and duration (Fig. 1A). The proportion of DRG neurons 
which responded to the opioid peptide appeared to vary as a function of culture 
dissection. That is, in all cultures derived from a single dissection, a similar percentage 
of DRG neurons responded to L-ENK. Some dissections produced cultures in which 
almost no neurons responded, while others produced cultures with the majority of 
neurons responding. The culture variable affecting DRG neuronal opiate sensitivity is 
unclear. 
Of the neurons which responded to L-ENK (84 of 115 responded to 1 #M), the 
magnitude of the effect on DRG somatic calcium-dependent action potentials varied 
considerably across neurons with effects produced by 1/zM L-ENK ranging from 2 to 
61 ~ ,  with a mean reduction of 18 ~.  Action potential duration was decreased maxi- 
mally immediately after application of L-ENK and then gradually returned to baseline 
duration over the next 1-2 min (Fig. 1B). Two to three minutes routinely separated 
successive applications of L-ENK. Using this paradigm the opioid peptide effect did 
not desensitize with repeated applications. 
It is unlikely that the observed decreases in action potential duration were due to 
pressure artifact. Firstly, decreases in action potential duration were not obtained by 
pressure ejection of control medium as long as care was taken to avoid osmolarity 
differences between the culture bathing medium and the medium contained in micro- 
pipettes for pressure ejection. Secondly, we have also observed L-ENK-mediated 
decreases in action potential duration when the opioid peptide was applied by super- 
fusion. 
Multiple concentrations of L-ENK tested on single DRG neurons produced 
dose-dependent decreases in the duration of somatic calcium-dependent action poten- 
tials over 20 nM to 5 #M (n = 23) (Fig. 2). L-ENK-mediated decreases in action 
potential duration were tested for sensitivity to naloxone antagonism. The paradigm 
followed was to obtain a control response to a 1 s application of L-ENK. Then a 
naloxone-containing rnicropipette was positioned near the DRG neuron which 
allowed the antagonist to diffuse into the medium surrounding the cell after which L- 
ENK was reapplied. Finally, the naloxone-containing micropipette was removed from 
its position near the DRG neuron, and L-ENK was reapplied. Naloxone reversibly 
antagonized decreases in calcium-dependent action potentials produced by L-ENK in 
a dose-dependent manner when tested on single DRG neurons (n -- 26). Reliable 
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Fig. 2. L-Enk reduced the duration of DRG neuron somatic calcium-dependent action potentials 
dose-dependently. Semilogarithmic plot of dose-dependent actions of L-ENK. Data represent mean 
responses of 6 DRG neurons each tested with 3 concentrations of L-ENK and which responded to 5 
ffM L-ENK with reductions in action potential duration greater than 20 ~.  Mean reduction in action 
potential duration of the 6 neurons by 5 ffM L-ENK was 4 4 ~  with a range of 24-57~. Since the 
magnitude of responses to L-ENK was highly variable from cell to cell, the data are plotted as 
response relative to that produced by 5 ttM L-ENK. L-ENK-induced decreases in the duration of 
calcium-dependent action potentials was underestimated since measurement of action potential 
duration included the delay in onset of the action potential as well as the duration of the sodium 
component. Bars represent standard error of the mean. Data are from 5 cultures and 5 sets of L-ENK- 
containing micropipettes. Dose-dependent action of L-ENK on a single DRG neuron is shown. 
Resting membrane potential was --65 mV. 
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Fig. 3. Naloxone antagonized L-ENK-induced decreases in DRG neuron somatic calcium-dependent 
action potential duration. Action potential duration was decreased from 12 to 6 ms following 
application of 1 #M L-ENK (A). After action potential duration had returned to baseline, a 
micropipette with tip diameter of about 20/~m and containing 10 nM, 100 nM or 1 ffM naloxone 
(NAL) was positioned to within 20 #m of the neuron. The naloxone was permitted to diffuse from the 
micropipette for 1 min prior to application of L-ENK. Naloxone did not antagonize L-ENK 
responses at 10 nM (B) or 100 nM (C) but did at a concentration of I ffM (D). Following removal of 
the 1 ffM naloxone containing micropipette from its position near the cell, application of L-ENK 
again decreased the duration of the calcium component of the action potential (E). Resting membrane 
potential was --63 mV. 
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We observed that L -ENK decreased the duration and amplitude of D R G  
neuron somatic calcium-dependent action potentials. L -ENK effects were dose-depen- 
dent and antagonized by naloxone, consistent with mediation by opiate receptors. Our 
findings correspond with those of Mudge et al. 29 who determined that D-AlaZ-Met - 
enkephalinamide decreased the calcium component of action potentials of chick D R G  
neurons in cell culture; in contrast, Williams and Zieglg~insberger 36 determined that 
opioid peptides did not affect calcium-dependent action potentials of  adult D R G  
somata. Technical differences may account for the different results. Alternatively, the 
results may be a function of the preparation used. While D R G  somata grown in 
primary dissociated culture have been demonstrated in this study to have functional 
opiate receptors, adult D R G  neuron somata may lack such receptors in vivo. In either 
case, the somatic membrane of cultured D R G  neurons with functional opiate 
receptors which act to decrease calcium influx may provide a model system for investi- 
gation relevant to mechanisms of opiate action to decrease transmitter release from 
primary afferents. 
Opiates have been shown to decrease transmitter release2,3,19,20,26,29,a4, 35, an 
action correlated with decreased calcium influx into synaptic terminalsS, 1~-15. Opiates 
have also been shown to decrease transmitter release from terminals of D R G  neurons 
grown in primary dissociated cell culture26, zg, an action correlated with reduction of 
the calcium component  of  D R G  somatic action potentials (Mudge et al. 29 and this 
study). Therefore, it is likely that the somata of  D R G  neurons grown in culture have 
opiate receptors which functionally are similar to synaptic terminal opiate receptors. 
lntracellular recording techniques cannot be applied to synaptic terminals of D R G  
neurons, making it impossible to directly study presynaptic opiate mechanisms. 
However, intracellular recording techniques can be applied to D R G  neuron somata to 
investigate the pharmacological characteristics of  opiate receptors on single D R G  
neurons as well as the coupling of opiate receptors with membrane ionic channels. 
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